PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Diarrhea 51,986 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.54
Infection 766,637 Disease Target A1AT 329 16 0.00 -0.98 0.05 0.54
Kidney Diseases 4,651 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.60
Bladder Cancer 21,509 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.59
AACT 109 Target Target A1AT 329 1 0.01 -0.99 0.01 0.70
Cathepsin G 1,613 Target Target A1AT 329 2 0.00 -1.00 0.01 0.65
Hepatitis B 57,815 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.58
Hyperbilirubinemia 5,757 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.61
Multiple Myeloma 24,594 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.56
ANGPTL4 289 Target Target A1AT 329 1 0.00 -1.00 0.00 0.69
Glomerulonephritis 23,459 Disease Target A1AT 329 6 0.00 -0.99 0.02 0.60
ERK1 18,374 Target Target A1AT 329 1 0.00 -1.00 0.00 0.56
AFP 9,751 Target Target A1AT 329 11 0.01 -0.98 0.03 0.65
Adiponectin 11,994 Target Target A1AT 329 2 0.00 -1.00 0.01 0.59
Influenza 67,933 Disease Target A1AT 329 1 0.00 -1.00 0.00 0.53
BNP 6,842 Target Target A1AT 329 1 0.00 -1.00 0.00 0.59
Shock 134,031 Disease Target A1AT 329 2 0.00 -1.00 0.01 0.53
Pneumonia 81,521 Disease Target A1AT 329 3 0.00 -1.00 0.01 0.55
Analgesia 44,857 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.59
Diabetes 332,602 Disease Target 744.1 22 1 0.00 -0.98 0.05 0.55
Obesity 138,233 Disease Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.57
APOE 12,771 Target Target 5-Hydroxytryptamine 6 Receptor 12 1 0.00 -0.96 0.08 0.63
Analgesia 44,857 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Platelet Aggregation 25,460 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.61
Seizure 44,685 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
5-Hydroxytryptamine 2b Receptor 18 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.03 -0.96 0.06 0.79
Diabetes 332,602 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.53
Glucocorticoid Receptor 10,306 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
CD4 112,219 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obesity 138,233 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.56
Depression 220,092 Disease Target 5-Hydroxytryptamine 2a Receptor 67 5 0.00 -0.96 0.07 0.57
Cancer 1,053,491 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Calmodulin 25,240 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.58
Anxiety 113,510 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Insomnia 12,434 Disease Target 5-Hydroxytryptamine 2a Receptor 67 3 0.00 -0.98 0.04 0.63
Hyperglycemia 28,168 Disease Target 5-Hydroxytryptamine 2a Receptor 67 2 0.00 -0.98 0.03 0.60
Infection 766,637 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.51
Schizophrenia 77,034 Disease Target 5-Hydroxytryptamine 2a Receptor 67 10 0.00 -0.92 0.15 0.61
Catechol O-Methyltransferase 2,877 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.64
Eating Disorders 9,000 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
ERK1 18,374 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.59
Adiponectin 11,994 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Phospholipase A2 13,400 Target Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Arthritis 128,324 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.55
Obsessive Compulsive Disorder 8,508 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.61
Headache 50,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.57
Attention Deficit Hyperactivity Disorder 14,687 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.60
Rheumatoid Arthritis 78,952 Disease Target 5-Hydroxytryptamine 2a Receptor 67 1 0.00 -0.99 0.01 0.56
Diabetes 332,602 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.55
744.1 22 Target Target 464.1 19 1 0.05 -0.95 0.05 0.83
Carcinoma 433,099 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.54
Cancer 1,053,491 Disease Target 464.1 19 2 0.00 -0.95 0.11 0.54
Prostate Cancer 71,064 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
Acute Promyelocytic Leukemia 4,780 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.65
Eotaxin 2,457 Target Target 464.1 19 1 0.00 -0.97 0.05 0.66
Renal Failure 73,993 Disease Target 464.1 19 1 0.00 -0.97 0.05 0.58
4-Mercaptopyridine 96 Drug Drug 4-Mercaptobenzoic Acid 70 2 0.02 -0.98 0.03 0.79
Carcinoma 433,099 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.52
Cancer 1,053,491 Disease Drug 4-Mercaptobenzoic Acid 70 4 0.00 -0.97 0.06 0.53
Dehydration 21,928 Disease Drug 4-Mercaptobenzoic Acid 70 1 0.00 -0.99 0.01 0.59
Hepatitis B 57,815 Disease Drug 4-Mercaptobenzoic Acid 70 2 0.00 -0.99 0.03 0.58
Graft Versus Host Disease 15,741 Disease Target 4-1BB Receptor 20 2 0.00 -0.95 0.10 0.63
CD4 112,219 Target Target 4-1BB Receptor 20 9 0.01 -0.74 0.45 0.62
Carcinoma 433,099 Disease Target 4-1BB Receptor 20 3 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
CD1A 2,739 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.63
Colon Cancer 30,064 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.52
Graft Versus Host Disease 15,741 Disease Target 4-1BB Ligand 135 2 0.00 -0.99 0.01 0.60
CD4 112,219 Target Target 4-1BB Ligand 135 36 0.01 -0.86 0.27 0.63
Obesity 138,233 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.53
Carcinoma 433,099 Disease Target 4-1BB Ligand 135 14 0.00 -0.95 0.10 0.57
Cervical Cancer 28,286 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.57
CEA 17,022 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.58
BAFF 1,240 Target Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.65
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
4-1BB Receptor 20 Target Target 4-1BB Ligand 135 9 0.17 -0.72 0.45 0.85
Conjunctivitis 8,825 Disease Target 4-1BB Ligand 135 1 0.00 -1.00 0.01 0.60
CD14 9,941 Target Target 4-1BB Ligand 135 3 0.00 -0.99 0.02 0.63
Infection 766,637 Disease Target 4-1BB Ligand 135 11 0.00 -0.96 0.08 0.55
Epidermal Growth Factor Receptor 24,772 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 3 0.00 -0.99 0.01 0.59
Colon Cancer 30,064 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.57
Lung Cancer 91,416 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 4 0.00 -0.99 0.02 0.56
Non Small Cell Lung Cancer 28,563 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 2 0.00 -1.00 0.01 0.58
Diabetes 332,602 Disease Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 9 0.00 -0.98 0.04 0.55
CD4 112,219 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 1 0.00 -1.00 0.00 0.53
Hypoglycemia 20,698 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.56
Platelet Aggregation 25,460 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.54
Meningitis 41,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Seizure 44,685 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.53
Diabetes 332,602 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.51
Glucocorticoid Receptor 10,306 Target Target 11-Beta-Hydroxylase 721 7 0.00 -0.99 0.01 0.62
Acne 11,364 Disease Target 11-Beta-Hydroxylase 721 5 0.00 -1.00 0.01 0.61
Obesity 138,233 Disease Target 11-Beta-Hydroxylase 721 2 0.00 -1.00 0.00 0.52
Carcinoma 433,099 Disease Target 11-Beta-Hydroxylase 721 19 0.00 -0.99 0.03 0.54
Endometriosis 16,342 Disease Target 11-Beta-Hydroxylase 721 1 0.00 -1.00 0.00 0.55
Hemorrhage 100,979 Disease Target 11-Beta-Hydroxylase 721 4 0.00 -1.00 0.01 0.54
Depression 220,092 Disease Target 11-Beta-Hydroxylase 721 8 0.00 -0.99 0.01 0.54
Cancer 1,053,491 Disease Target 11-Beta-Hydroxylase 721 10 0.00 -0.99 0.01 0.51